March 3, 2026Open Access

Disulfidptosis-related genes signature predicts prognosis and immune microenvironment in colon cancer

Key Points

The 5-DRGs prognostic model accurately assesses patient prognosis in colon cancer and reflects immune microenvironment characteristics.
Key factors RAB7A and OXSM significantly influence the prognostic model, enhancing its predictive capabilities.
The use of the disulfidptosis-related genes signature offers a framework for effective risk stratification in colon cancer patients.
Further applications of this model may enable personalized treatment strategies, improving outcomes among patients.

Abstract

The 5-DRGs prognostic model can be used to assess the prognosis of patients with CC, and reflect the characteristics of their immune microenvironment. With RAB7A and OXSM as key determinants, this model provides a clinically applicable framework for risk stratification and personalized treatment guidance.

Bookmark

View Full Paper

Cite This Study

Jiang et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75cb8c6e9836116a25d3d https://doi.org/https://doi.org/10.3389/fmolb.2026.1756041

Bookmark

View Full Paper